He Ding, Chen Hong, Zeng Ming, Xia Chunmei, Wang Jin, Shen Linlin, Zhu Danian, Chen Yonghua, Wang Jijiang
Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Front Neurosci. 2020 Jan 31;14:31. doi: 10.3389/fnins.2020.00031. eCollection 2020.
Airway vagal hypertonia is closely related to the severity of asthma; however, the mechanisms of its genesis are unclear. This study aims to prove that asthmatic airway vagal hypertonia involves neuronal Cl dyshomeostasis. The experimental airway allergy model was prepared with ovalbumin in male adult Sprague-Dawley rats. Plethysmography was used to evaluate airway vagal response to intracisternally injected γ-aminobutyric acid (GABA). Immunofluorescent staining and Western-blot assay were used to examine the expression of microglia-specific proteins, Na-K-2Cl co-transporter 1 (NKCC1), K-Cl co-transporter 2 (KCC2) and brain-derived nerve growth factor (BDNF) in airway vagal centers. Pulmonary inflammatory changes were examined with hematoxylin and eosin staining of lung sections and ELISA assay of ovalbumin-specific IgE in bronchoalveolar lavage fluid (BALF). The results showed that histochemically, experimental airway allergy activated microglia, upregulated NKCC1, downregulated KCC2, and increased the content of BDNF in airway vagal centers. Functionally, experimental airway allergy augmented the excitatory airway vagal response to intracisternally injected GABA, which was attenuated by intracisternally pre-injected NKCC1 inhibitor bumetanide. All of the changes induced by experimental airway allergy were prevented or mitigated by chronic intracerebroventricular or intraperitoneal injection of minocycline, an inhibitor of microglia activation. These results demonstrate that experimental airway allergy augments the excitatory response of airway vagal centers to GABA, which might be the result of neuronal Cl dyshomeostasis subsequent to microglia activation, increased BDNF release and altered expression of Cl transporters. Cl dyshomeostasis in airway vagal centers might contribute to the genesis of airway vagal hypertonia in asthma.
气道迷走神经张力亢进与哮喘严重程度密切相关;然而,其发生机制尚不清楚。本研究旨在证明哮喘气道迷走神经张力亢进涉及神经元氯离子稳态失衡。用卵清蛋白在成年雄性Sprague-Dawley大鼠中制备实验性气道过敏模型。采用体积描记法评估气道迷走神经对脑池内注射γ-氨基丁酸(GABA)的反应。免疫荧光染色和蛋白质免疫印迹法检测气道迷走神经中枢中小胶质细胞特异性蛋白、钠-钾-2氯协同转运蛋白1(NKCC1)、钾-氯协同转运蛋白2(KCC2)和脑源性神经生长因子(BDNF)的表达。用苏木精-伊红染色观察肺组织切片的炎症变化,并用酶联免疫吸附测定法检测支气管肺泡灌洗液(BALF)中卵清蛋白特异性IgE的含量。结果显示,组织化学上,实验性气道过敏激活了小胶质细胞,上调了NKCC1,下调了KCC2,并增加了气道迷走神经中枢中BDNF的含量。功能上,实验性气道过敏增强了气道迷走神经对脑池内注射GABA的兴奋性反应,而脑池内预先注射NKCC1抑制剂布美他尼可减弱该反应。慢性脑室内或腹腔注射小胶质细胞激活抑制剂米诺环素可预防或减轻实验性气道过敏引起的所有变化。这些结果表明,实验性气道过敏增强了气道迷走神经中枢对GABA的兴奋性反应,这可能是小胶质细胞激活、BDNF释放增加和氯离子转运体表达改变导致神经元氯离子稳态失衡的结果。气道迷走神经中枢的氯离子稳态失衡可能有助于哮喘气道迷走神经张力亢进的发生。